NCT07215546
Enhanced Sternal Closure With Montage or Montage-CT to Evaluate Post-Operative Opioid Use Following Median Sternotomy
Enrolling by Invitation
Not specifiedAges 19–80ObservationalAbyrx, Inc.
~150 participants
Updated 2025-10-10 on ClinicalTrials.gov
What's tested:Montage or Montage CT
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cumulative Opiod Dose
Measured over From admission until end of treatment/discharge, up to 8 weeks
Conditions
Where it's being run
2 sites across 2 statesFlorida1
Missouri1
Study leadership
- Aniq Darr, Ph.D. · STUDY_DIRECTOR · Abyrx, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Cumulative Opiod DoseFrom admission until end of treatment/discharge, up to 8 weeks
1\. Cumulative opioid dose (COD) is measured from entry into the postoperative ICU through the time of achieving hospital discharge criteria. Opioid use will be quantified in morphine equivalents, using conversion factors based on Von Korff, et al.